Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - General industry. The company is headquartered in Princeton, DE, United States. The current CEO is Christopher S. Boerner.
BMYMP has IPO date of 2003-12-08, 34,100 full-time employees, listed on the Other OTC.
Bristol-Myers Squibb is a global pharmaceutical company that discovers, develops, and markets innovative drugs across multiple therapeutic areas, including cardiovascular disease, cancer, and immune disorders. The company has established itself as a leader in immuno-oncology, a rapidly growing field combining immunotherapy with cancer treatment. With approximately 70% of its revenue generated from the United States market, Bristol-Myers Squibb demonstrates a significant concentration in the U.S. compared to many of its industry peers, reflecting its strong presence in the world's largest pharmaceutical market.
